Clinical Trial Update: GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gemcitabine/cisplatin/S-1 versus gemcitabine/cisplatin for biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Kansai Hepatobiliary Oncology Group | Conditions: Biliary Tract Cancer | Phase 3 | Status: COMPLETED